Knockout of insulin receptors in cardiomyocytes attenuates coronary arterial dysfunction induced by pressure overload.

Ablating insulin receptors in cardiomyocytes causes subendocardial fibrosis and left ventricular (LV) dysfunction after 4 wk of transverse aortic constriction (TAC). To determine whether these maladaptive responses are precipitated by coronary vascular dysfunction, we studied mice with cardiomyocyte-restricted knock out of insulin receptors (CIRKO) and wild-type (WT) TAC mice before the onset of overt LV dysfunction. Two weeks of TAC produced comparable increases (P < 0.05 vs. respective sham) in heart weight/body weight (mg/g) in WT-TAC (8.03 ± 1.14, P < 0.05 vs. respective sham) and CIRKO-TAC (7.76 ± 1.25, P < 0.05 vs. respective sham) vs. WT-sham (5.64 ± 0.11) and CIRKO-sham (4.64 ± 0.10) mice. In addition, 2 wk of TAC were associated with similar LV geometry and function (echocardiography) and interstitial fibrosis (picrosirius red staining) in CIRKO and WT mice. Responses to acetylcholine (ACh), N(G)-monomethyl-L-arginine (l-NMMA), and sodium nitroprusside (SNP) were measured in coronary arteries that were precontracted to achieve ∼70% of maximal tension development using the thromboxane A(2) receptor mimetic U-46619 (∼3 × 10(-6) M). ACh-evoked vasorelaxation was absent in WT-TAC but was present in CIRKO-TAC albeit reduced relative to sham-operated animals. l-NMMA-evoked tension development was similar in vessels from CIRKO-TAC mice but was lower (P < 0.05) in WT-TAC animals vs. the respective sham-operated groups, and SNP-evoked vasorelaxation was similar among all mice. Thus estimates of stimulated and basal endothelial nitric oxide release were better preserved in CIRKO vs. WT mice in response to 2 wk of TAC. These findings indicate that maladaptive LV remodeling previously observed in CIRKO-TAC mice is not precipitated by coronary artery dysfunction, because CIRKO mice exhibit compensatory mechanisms (e.g., increased eNOS transcript and protein) to maintain coronary endothelial function in the setting of pressure overload.

[1]  E. Abel,et al.  Endothelial nitric oxide synthase phosphorylation in treadmill‐running mice: role of vascular signalling kinases , 2009, The Journal of physiology.

[2]  E. Abel,et al.  Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarction. , 2009, Journal of molecular and cellular cardiology.

[3]  J. Tanner,et al.  Contribution of Insulin and Akt1 Signaling to Endothelial Nitric Oxide Synthase in the Regulation of Endothelial Function and Blood Pressure , 2009, Circulation research.

[4]  S. Boudina,et al.  Contribution of Impaired Myocardial Insulin Signaling to Mitochondrial Dysfunction and Oxidative Stress in the Heart , 2009, Circulation.

[5]  Athanasia Spandidos,et al.  A comprehensive collection of experimentally validated primers for Polymerase Chain Reaction quantitation of murine transcript abundance , 2008, BMC Genomics.

[6]  F. Gonzalez,et al.  Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1. , 2008, Cell metabolism.

[7]  M. Muckenthaler Fine tuning of hepcidin expression by positive and negative regulators. , 2008, Cell metabolism.

[8]  F. Gonzalez,et al.  Distinct Functions of Vascular Endothelial and Smooth Muscle PPARγ in Regulation of Blood Pressure and Vascular Tone , 2008, Toxicologic pathology.

[9]  W. Bremner,et al.  Advances in male contraception. , 2008, Endocrine reviews.

[10]  J. Berger,et al.  Cardiac hypertrophy caused by peroxisome proliferator- activated receptor-gamma agonist treatment occurs independently of changes in myocardial insulin signaling. , 2007, Endocrinology.

[11]  M. Birnbaum,et al.  A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. , 2007, Cell metabolism.

[12]  R. Muniyappa,et al.  Cardiovascular actions of insulin. , 2007, Endocrine reviews.

[13]  R. Muniyappa,et al.  Insulin action and insulin resistance in vascular endothelium , 2007, Current opinion in clinical nutrition and metabolic care.

[14]  R. Bruno,et al.  A quercetin supplemented diet does not prevent cardiovascular complications in spontaneously hypertensive rats. , 2007, The Journal of nutrition.

[15]  S. Litwin,et al.  Quercetin-Supplemented Diets Lower Blood Pressure and Attenuate Cardiac Hypertrophy in Rats With Aortic Constriction , 2006, Journal of cardiovascular pharmacology.

[16]  E. Abel,et al.  Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density. , 2005, Journal of molecular and cellular cardiology.

[17]  C. Keen,et al.  Reducing Arginase Activity via Dietary Manganese Deficiency Enhances Endothelium-Dependent Vasorelaxation of Rat Aorta , 2004, Experimental biology and medicine.

[18]  R. Cooksey,et al.  Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. , 2004, Diabetes.

[19]  J. Symons,et al.  Improved coronary vascular function evoked by high-intensity treadmill training is maintained in arteries exposed to ischemia and reperfusion. , 2003, Journal of applied physiology.

[20]  E. Abel,et al.  Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. , 2003, American journal of physiology. Heart and circulatory physiology.

[21]  J. Rutledge,et al.  Hyperhomocysteinemia Evoked by Folate Depletion: Effects on Coronary and Carotid Arterial Function , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[22]  C. Kahn,et al.  Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. , 2002, The Journal of clinical investigation.

[23]  S. Dimmeler,et al.  Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. , 2001, The Journal of clinical investigation.

[24]  Jack A. M. Leunissen,et al.  Turning CFCs into salt. , 1996, Nucleic Acids Res..

[25]  A. M. Lefer,et al.  Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[26]  J. Rutledge,et al.  Vascular dysfunction produced by hyperhomocysteinemia is more severe in the presence of low folate. , 2006, American journal of physiology. Heart and circulatory physiology.

[27]  M. Brownlee Insight Review Articles , 2022 .